Hepatitis E Vaccines Market Forecast to USD 247.5 million by 2034, Growing 20.62% a Year
Market reaches USD 247.5 million by 2034, up from USD 45.6 million in 2025, at a 20.62% CAGR.
Market findings and research announcements from the CDI research team. Showing 1–12 of 101.
Market reaches USD 247.5 million by 2034, up from USD 45.6 million in 2025, at a 20.62% CAGR.
Market reaches USD 56.74 billion by 2034, up from USD 28.5 billion in 2025, at a 8.21% CAGR.
Market reaches USD 55 billion by 2034, up from USD 26 billion in 2025, at a 8.71% CAGR.
From USD 1.42 billion in 2025 to USD 2.58 billion in 2034, a 6.93% compound annual rate.
From USD 6.85 billion in 2025 to USD 12.48 billion in 2034, a 6.93% compound annual rate.
Market reaches USD 15.68 billion by 2034, up from USD 11.85 billion in 2025, at a 3.08% CAGR.
Market reaches USD 372 million by 2034, up from USD 162 million in 2025, at a 9.65% CAGR.
From USD 1.38 billion in 2025 to USD 2.64 billion in 2034, a 7.5% compound annual rate.
Market reaches USD 1414.2 million by 2034, up from USD 690 million in 2025, at a 8.31% CAGR.
From USD 32.5 billion in 2025 to USD 86.65 billion in 2034, a 11.64% compound annual rate.
Market reaches USD 16.91 billion by 2034, up from USD 8.9 billion in 2025, at a 7.34% CAGR.
Market reaches USD 31.85 billion by 2034, up from USD 12.5 billion in 2025, at a 10.77% CAGR.
For comment on a published finding, or to request the full study behind a release, contact the research team.